1,330.00p-40.00 (-2.92%)02 Dec 2021, 18:02
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Ergomed PLC Fundamentals

Company NameErgomed PLCLast Updated2021-12-02
IndustryBiotechnologySectorHealthcare
Shares in Issue49.132 mMarket Cap£653.46 m
PE Ratio57.47Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£0.19EPS Growth (%)0.36
PEG0DPS Growth (%)0
Debt Ratio0.0396Debt Equity Ratio0.0412
Asset Equity Ratio1.6148Cash Equity Ratio0.4169
Quick Ratio1.5331Current Ratio1.60
Price To Book Value11.0865ROCE0

Ergomed PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Ergomed PLC Company Financials

Assets202020192018
Tangible Assets£6.46 m£6.28 m£1.34 m
Intangible Assets£34.22 m£16.14 m£17.40 m
Investments00£2.06 m
Total Fixed Assets£45.58 m£25.03 m£21.39 m
Stocks000
Debtors£25.87 m£16.23 m£18.03 m
Cash & Equivalents£18.99 m£14.26 m£5.19 m
Other Assets000
Total Assets£92.35 m£57.03 m£46.86 m
Liabilities202020192018
Creditors within 1 year£33.61 m£15.86 m£17.19 m
Creditors after 1 year£5.87 m£4.35 m£1.31 m
Other Liabilities000
Total Liabilities£39.48 m£20.21 m£18.50 m
Net assets£52.87 m£36.82 m£28.36 m
Equity202020192018
Called up share capital£489,000.00£473,000.00£452,000.00
Share Premium£3,000.00£25.79 m£24.38 m
Profit / Loss£12.63 m£4.99 m-£10.77 m
Other Equity£52.87 m£36.82 m£28.36 m
Preference & Minorities000
Total Capital Employed£52.87 m£36.82 m£28.36 m
Ratios202020192018
Debt Ratio£0.06£0.090
Debt-to-Equity£0.06£0.100
Assets / Equity1.61481.61481.6148
Cash / Equity0.41690.41690.4169
EPS£0.23£0.17-£0.08
Cash Flow202020192018
Cash from operating activities£18.05 m£11.79 m£2.10 m
Cashflow before financing£17.57 m£11.54 m£5.87 m
Increase in Cash£4.79 m£8.71 m£2.08 m
Income202020192018
Turnover£86.39 m£68.25 m£54.11 m
Cost of sales£46.74 m£38.73 m£34.86 m
Gross Profit£39.65 m£29.52 m£19.25 m
Operating Profit£13.53 m£5.52 m-£10.45 m
Pre-Tax profit£12.63 m£4.99 m-£10.77 m

Ergomed PLC Company Background

SectorHealthcare
ActivitiesErgomed PLC is engaged in the healthcare sector. Its business involves the provision of drug development services to the pharmaceutical industry. The company operates through two segments: Clinical Research Outsourcing and Pharmacovigilance. It provides clinical development services to clients ranging from top 10 pharmaceutical companies to small and mid-sized drug development companies. The PV segment has expertise in the field of pharmacovigilance and provides medical information services.
Latest Interim Date28 Sep 2021
Latest Fiscal Year End Date23 Mar 2021

Ergomed PLC Directors

AppointedNamePosition
2019-06-18Mr. Stuart Robert JacksonExecutive Director,Chief Financial Officer
2021-06-17Mr. Rolf Kristian Soderstrom Non-Executive Director,Senior Independent Director
2021-04-29Mr. Ian Roy Johnson Non-Executive Director
2021-08-18Mr. Richard Timothy BarfieldExecutive Director,Chief Financial Officer
2018-05-21Mr. Rolf StahelNon-Executive Director,Chairman
2018-05-22Mr. Neil Robert ClarkExecutive Director,Chief Executive Officer, PrimeVigilance
2019-05-17Mr. Stephen Anthony Stamp Executive Director,Chief Executive Officer
2019-09-25Mr. Peter Lutz GeorgeNon-Executive Director
2021-08-18Dr. Miroslav ReljanovicExecutive Director,Chairman
2019-03-11Mr. Christopher CollinsNon-Executive Director
2019-05-17Mr. Andrew MackieExecutive Director,Chief Business Officer
2018-05-22Mr. Sanja Juric Company Secretary
2019-09-18Dr. Jan PetracekExecutive Director,Chief Operating Officer
2020-05-15Dr. James Douglas Esinhart Non-Executive Director
2020-09-22Mr. Lewis Cameron Executive Director,Chief Operating Officer

Ergomed PLC Contact Details

Company NameErgomed PLC
Address1 Occam Court, The Surrey Research Park, Guildford, GU2 7HJ
Telephone+44 1483503205
Websitehttp://www.ergomedplc.com

Ergomed PLC Advisors

StockbrokerN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
Financial PR AdviserMC Services AG
Phone+49 892102280
Fax+49 8921022888
Nominated AdviserNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
StockbrokerNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
RegistrarShare Registrars Limited
Phone+44 1252821390
Fax+44 1252719232
AuditorDeloitte LLP
Phone+44 1223460222
Fax+44 1223350839
SolicitorCovington & Burling LLP
Phone+44 2070672000
Fax +44 2070672222